New comprehensive guidance for the diagnosis and management of peanut and tree nut allergy has been developed, which for the first time brings together the latest research and expert views into a single robustly written document. ...
Jun 5, 2017
0
8
CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...
Jan 12, 2017
0
88
Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions. The study, "Kinesin-1 controls mast cell degranulation and anaphylaxis ...
Oct 24, 2016
0
0
A five-fold price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.
Aug 23, 2016
1
3
Millions of Americans with severe allergies and asthma are prescribed medical devices to help relieve symptoms and sometimes, to treat potentially fatal allergic reactions. Unfortunately, very few people use their prescribed ...
Dec 18, 2014
0
0
Of all foods, peanuts are the most frequent cause of life-threatening and fatal allergic reactions. New research at National Jewish Health provides additional support for a strategy to reduce the severity of reactions to ...
Jan 10, 2013
0
0
